Nivolumab Promising for Advanced Melanoma

Results of a phase 1 trial may raise expectations for better outcomes with lower toxicity.

Idelalisib, Rituximab Combo Effective for Relapsed CLL

Rituximab combined with idelalisib may offer a tolerable alternative therapy for patients with chronic lymphocytic leukemia.

Effect of Bariatric Surgery on Endometrial Cancer Risk

Reversing obesity may also reduce a woman's chance of developing uterine cancer.

Palbociclib for Hormone Receptor-positive Breast Cancer

A phase 2 study finds that an inhibitor of CDK-4 and CDK-6 reduced the risk of disease progression by 51%.

Enter Our April Contest and Win A Nike Fuel Band!

Become an Oncology Practice Pro by participating in this month's contest. Three lucky participants will win a Nike Fuel Band!

Does Palliative Chemotherapy Really Palliate?

Many patients believe that palliative chemo is curative treatment, so oncologists need to have important end-of-life discussions early in the course of cancer care.

Featured Videos


Latest News

Combined Tobacco, Alcohol Use Spikes Esophageal Cancer Risk

Rates of esophageal squamous cell carcinoma (ESCC) nearly double for those who use tobacco and consume alcohol, compared to individuals who only smoke or drink.

Before HPV Vaccine, Most Oropharyngeal Cancers Were HPV+

Most oropharyngeal cancers in the United States diagnosed between 1995 and 2005 were positive for human papillomavirus, specifically HPV 16 or 18.

ASCO: Screen Cancer Patients for Anxiety, Depression

It is important to recognize and treat anxiety or depression among cancer patients, according to a clinical guideline published online.

Viewpoints & Cases

Idelalisib Plus Rituximab Highly Effective for Relapsed CLL

Idelalisib Plus Rituximab Highly Effective for Relapsed CLL

Resistance to initial therapy for patients with CLL may limit treatment options; however, rituximab combined with the PI3K inhibitor idelalisib may offer a tolerable alternative therapy.

Bariatric Surgery May Help Prevent Endometrial Cancer

Bariatric Surgery May Help Prevent Endometrial Cancer

Reversing obesity may also reduce a woman's chance of developing uterine cancer.

A 58-year-old with Stage IV Pancreatic Adenocarcinoma

A 58-year-old with Stage IV Pancreatic Adenocarcinoma

Chief Complaint

R.M. is a 58-year-old male recently diagnosed with stage IV pancreatic adenocarcinoma (Slide 1). He is a mechanical engineer ...

A 55-year-old Woman with Breast Cancer and Shortness of Breath

A 55-year-old Woman with Breast Cancer and Shortness of Breath

Chief Complaint

J.W. is a 55-year-old woman recently admitted to the hospital for worsening shortness of breath (Slide 1).

Relevant Medical History

• ...

From the Board

Expert Perspectives on Breast Cancer Awareness Month

Editorial Board Member Don Dizon, MD, answers some questions about issues in breast cancer treatment today.

Reflections on Patient Perspectives and Survivorship from the 2013 Breast Cancer Symposium

ChemotherapyAdvisor.com Editorial Board Member Don S. Dizon discusses survivorship issues from the 2013 Breast Cancer Symposium.

Editorial Advisory Board

 

Barbara Ann Burtness, MD

Steven Cohen, MD

E. David Crawford, MD

Don S. Dizon, MD, FACP

Jeffrey M. Farma, MD

Edith A. Perez, MD

Neal D. Shore, MD, FACS

Mark A. Socinski, MD

Martin Tallman, MD

Click here for complete profiles

Poll Question


News from Oncology Nurse Advisor

Sign Up for Free e-newsletters

Enter Our April Contest

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs